Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Total Current Liabilities: ₹111 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MADHAVBAUG Vaidya Sane Ayurved Laboratories Ltd NSE:MADHAVBAUG
78 GF Score
Price ₹204.85
GF Value ₹228.14
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Vaidyane Ayurved Laboratories Total Current Liabilities?

Vaidyane Ayurved Laboratories NSE:MADHAVBAUG +0.49% 78 Total Current Liabilities is ₹111 Mil as of Mar. 2026. GuruFocus rates NSE:MADHAVBAUG with a GF Score™ of 78/100 and a GF Value™ of ₹228.14 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Vaidyane Ayurved Laboratories's total current liabilities for the quarter that ended in Mar. 2026 was ₹111

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Vaidyane Ayurved Laboratories Total Current Liabilities Related Terms

Vaidyane Ayurved Laboratories Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Vaidyane Ayurved Laboratories's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaidyane Ayurved Laboratories Total Current Liabilities Chart

Vaidyane Ayurved Laboratories Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Current Liabilities
Get a 7-Day Free Trial 142.59 128.76 116.19 112.25 111.11

Vaidyane Ayurved Laboratories Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 116.19 113.63 112.25 110.56 111.11
NSE:MADHAVBAUG
78GF Score
Vaidya Sane Ayurved Laboratories Ltd NSE:MADHAVBAUG
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaidyane Ayurved Laboratories Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Vaidyane Ayurved Laboratories's Total Current Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=65.683+0
+Other Current Liabilities+Current Deferred Liabilities
=45.426+0
=111

Vaidyane Ayurved Laboratories's Total Current Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=65.683+0
+Other Current Liabilities+Current Deferred Liabilities
=45.426+0
=111

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of ₹111 Mil mean?
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) has a Total Current Liabilities of ₹111 Mil as of Mar. 2026. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Vaidyane Ayurved Laboratories and its competitors.
Is Vaidyane Ayurved Laboratories' Total Current Liabilities too high?
Vaidyane Ayurved Laboratories' current Total Current Liabilities is ₹111 Mil. Overall, Vaidyane Ayurved Laboratories has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vaidyane Ayurved Laboratories' Total Current Liabilities compare to ZTS and UTHR?
Vaidyane Ayurved Laboratories' Total Current Liabilities of ₹111 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Drug Manufacturers company?
A good Total Current Liabilities depends on the Drug Manufacturers industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Vaidyane Ayurved Laboratories and its competitors. Vaidyane Ayurved Laboratories's current Total Current Liabilities is ₹111 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaidyane Ayurved Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹228.14, compared to a current price of ₹204.85 — trading 10.2% below its estimated fair value. The current Total Current Liabilities is ₹111 Mil. Vaidyane Ayurved Laboratories' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG), the current Total Current Liabilities is ₹111 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Overvalued in 2026?

Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories stock appears to be undervalued. The current stock price of ₹204.85 is trading 10.2% below its estimated GF Value™ of ₹228.14. GuruFocus considers Vaidyane Ayurved Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:MADHAVBAUG:

  • Total Current Liabilities: ₹111 Mil
  • GF Value™: ₹228.14 vs. price of ₹204.85 (10.2% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the NSE:MADHAVBAUG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vaidyane Ayurved Laboratories Business Description

Address 201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution. The company engaged in research and development in Ayurvedic Medicines and the sale of Ayurvedic medicines & products through its various franchises and own clinics. The Company is also engaged in providing Ayurved medical professional services across its various clinics, including panchkarma and other Ayurvedic treatments through the running of an Ayurvedic Hospital. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management, and knee pain relief. The company's business is divided into three segments, i.e., Hospital Activity, Sale of Product, and Common. It derives maximum revenue from the sale of Products.
78GF Score

Get the complete analysis for NSE:MADHAVBAUG

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹204.85
Price
₹228.14
GF Value